Neurogene, Inc. (NGNE)
22.04
+1.30
(+6.27%)
USD |
NASDAQ |
Mar 03, 16:00
22.04
0.00 (0.00%)
After-Hours: 20:00
Neurogene Price : 22.04 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Taysha Gene Therapies, Inc. | 4.515 |
| ACADIA Pharmaceuticals, Inc. | 22.50 |
| Agenus, Inc. | 3.185 |
| Alnylam Pharmaceuticals, Inc. | 318.75 |
| Savara, Inc. | 5.575 |
Price Related Metrics
| Price to Book Value | 1.286 |
| Earnings Yield | -20.09% |
| Market Cap | 341.40M |